The biotech sector has had a cruel start to the year. The Nasdaq Biotechnology Index (IBB) is down 23% so far in 2016, …
Gilead Sciences, Inc. (NASDAQ:GILD) announced the promotion of Katie Watson to Executive Vice President, Human Resources.
Gilead Sciences, Inc. (NASDAQ:GILD) announced that the company’s Type II variation application for once-daily Truvada® (emtricitabine 200mg/tenofovir disoproxil fumarate 300mg) in combination with safer …
John Sonnier of William Blair weighs in on pharmaceuticals giants Celgene Corporation (NASDAQ:CELG) and Gilead Sciences, Inc. (NASDAQ:GILD) in light of earnings and …
Wall Street has a busy week ahead packed with earnings from these stock giants. Find out what to watch for in reports from …
As tech markets become increasingly difficult to navigate, Apple Inc. (NASDAQ:AAPL)’s and Intel Corporation (NASDAQ:INTC)’s futures are pushing to hold.
Gilead Sciences, Inc. (NASDAQ:GILD) announced that, effective March 10, 2016, current Chairman and CEO John C.
The biotechnology sector is always volatile, and the recent market sell-off only makes it more so. Consequently, Alan Carr of Needham notes that …
Credit Suisse analyst Alethia Young came out today with new ratings and price targets on a handful of healthcare stocks. Let’s take a …
Gilead Sciences, Inc. (NASDAQ:GILD) and Galapagos NV (ADR) (NASDAQ:GLPG) announced the closing and entry into force of their global license and collaboration agreement …
